Organizational Overview:

Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As a leader in FcRn inhibitor technology, we are boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs. Our investigational compound, batoclimab, is a novel, fully human, monoclonal antibody targeting the neonatal Fc receptor (FcRn). Optimized as a subcutaneous injection with flexibility in dosing and approach, batoclimab is designed to reduce immunoglobin G (IgG) antibodies that cause inflammation and disease.

The Role:

Reporting to the VP of Clinical Operations, the Director, TMF Operations is responsible for providing strategic, planning, oversight and delivery of the clinical documentation function throughout the lifecycle of clinical development programs. This role will work collaboratively and strategically with VP of Clinical Operations and our cross-functional teams and external partners to establish standards for TMF-related activities including: implementation of a global eTMF system including TMF related SOPs, processes and best practices; development of metrics and tracking of eTMF performance to ensure and promote a continuous state of audit readiness, and compliance with regulatory requirements and the principles and standards of GCP, as well as GDPR standards.

Key Responsibilities: 

  • Define and build Immunovant’s eTMF program including cross-functional resource needs, quality/system technical requirements, accountable for eTMF system alignment across functions
  • Establish company-wide standards for TMF-related activities including document quality standards; lead efforts to drive adoption of innovations related to TMF performance management to optimize risk-based quality management and enhance analytic capabilities enabling a proactive approach to ensure compliance with regulatory requirements
  • Manage TMF performance objectives for end-to-end processes ensuring quality, timeliness, and completeness throughout the lifecycle of the study by overseeing and/or ensuring ongoing reviews to confirm documents are collected and maintained in accordance with ICH guidelines and global regulatory requirements
  • Provide technical oversight and liaise with cross-functional partners to support ongoing TMF system maintenance and enhancements in accordance with system-related regulations and guidance documents
  • Provide SME and liaise with cross-functional partners to define and manage document structure, repositories, inventory, and access for on-site clinical documentation storage in accordance with procedures and global standards
  • Oversight accountability to ensure all clinical documentation is being collected, handled, transferred, stored via secure and authorized methods, ensuring compliance with GDPR standards and local privacy requirement standards including identification of any systems or processes necessary to fulfill requirements
  • Accountable to develop and/or oversee the risk-based TMF oversight strategy and workstream in collaboration with cross-functional team including portfolio-level clinical documentation related risk identification, management, and mitigation efforts and report progress to senior leadership
  • Respond to and participate in Quality Assurance audits and/or regulatory authority inspections
  • Accountable for overall clinical documentation performance of regulated clinical trials including eTMF inspection readiness; responsible for oversight of regular quality checks including results reporting to senior leadership
  • Contribute to the development and improvement of department-level and cross-functional Standard Operating Procedures (SOPs), processes, systems, tools

Requirements: 

  • B.S./B.A. degree required, advanced degree highly desirable
  • 8+ years’ clinical research with progressive management experience in clinical documentation space (minimum 4 years of direct TMF oversight experience)
  • Experience in gene therapy, rare/orphan disease and/or late phase trials is highly desirable
  • Experience designing, standardizing, and implementing TMF strategies and standards for global development programs is required
  • Experience in managing CROs performing TMF activities is required; experience with Veeva Vault is highly desirable
  • Experience implementing and overseeing a TMF system is required
  • Experience with all aspects of clinical trial conduct (startup through close-out) is required
  • Experience overseeing the transition of TMF activities from an outsourced vendor to insource is highly preferred
  • Experience in regulatory filings (e.g., NDA, BLA, MAA) is highly desired
  • Ability and willingness to travel up to 10% of the time, as needed (domestic)
  • Ability to function at a high level in a team setting whether leading the group or acting as an individual contributor Understanding of drug development and program management from pre-IND through regulatory filing is essential
  • Demonstrated excellence in complex project management and effective management of multiple projects/priorities
  • Must have demonstrated ability to solve problems with innovative solutions along with strong organizational skills. Excellent written and verbal communication skills are required.
  • Previous involvement in the oversight and management of GCP regulatory inspections required

Work Environment: 

  • Dynamic, interactive, fast-paced, and entrepreneurial environment
  • Immunovant’s headquarters is located in New York City. The position is flexible for remote work.
  • Domestic travel required (up to 10%)

 

Apply for this Job

* Required
  
  


Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in IMVT Corporation’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.


Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

1Section 503 of the Rehabilitation Act of 1973, as amended. For more information about this form or the equal employment obligations of Federal contractors, visit the U.S. Department of Labor's Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.